- Report
- September 2026
- 190 Pages
Global
From €3289EUR$3,545USD£2,744GBP
€3655EUR$3,939USD£3,049GBP
- Report
- September 2026
- 197 Pages
Global
From €3289EUR$3,545USD£2,744GBP
€3655EUR$3,939USD£3,049GBP
- Report
- September 2026
- 193 Pages
Global
From €3289EUR$3,545USD£2,744GBP
€3655EUR$3,939USD£3,049GBP
- Report
- September 2026
- 184 Pages
Global
From €3289EUR$3,545USD£2,744GBP
€3655EUR$3,939USD£3,049GBP
- Report
- September 2026
- 198 Pages
Global
From €3289EUR$3,545USD£2,744GBP
€3655EUR$3,939USD£3,049GBP
- Report
- November 2026
- 586 Pages
Global
From €5428EUR$5,850USD£4,528GBP
- Report
- August 2026
- 120 Pages
Global
From €4408EUR$4,750USD£3,677GBP
- Report
- July 2026
- 130 Pages
Global
From €4408EUR$4,750USD£3,677GBP
- Report
- April 2026
- 105 Pages
Global
From €4408EUR$4,750USD£3,677GBP
- Report
- July 2026
- 130 Pages
Global
From €4408EUR$4,750USD£3,677GBP
- Report
- July 2026
- 160 Pages
Global
From €3081EUR$3,320USD£2,570GBP
€3851EUR$4,150USD£3,212GBP
- Report
- November 2025
- 160 Pages
Global
From €2932EUR$3,160USD£2,446GBP
€3665EUR$3,950USD£3,057GBP
- Report
- February 2026
Global, Africa, Middle East Global, Africa, Middle East
From €3201EUR$3,450USD£2,670GBP
- Report
- August 2026
- 125 Pages
Global
From €3500EUR$4,041USD£3,022GBP
- Report
- July 2026
- 86 Pages
Middle East
From €4408EUR$4,750USD£3,677GBP
- Report
- July 2026
- 90 Pages
Europe
From €4408EUR$4,750USD£3,677GBP
- Report
- July 2026
- 70 Pages
Europe
From €4408EUR$4,750USD£3,677GBP
- Report
- August 2026
- 70 Pages
United States
From €4408EUR$4,750USD£3,677GBP
- Report
- March 2026
- 150 Pages
United States
From €4500EUR$4,850USD£3,754GBP
- Report
- February 2026
- 150 Pages
United States
From €4500EUR$4,850USD£3,754GBP

The HbA1C Testing market within the Biotechnology industry is a rapidly growing sector. It is used to measure the average amount of glucose in the blood over a period of two to three months. This test is used to diagnose and monitor diabetes, as well as to assess the effectiveness of diabetes treatments. It is also used to detect pre-diabetes and to monitor the risk of developing diabetes.
The HbA1C Testing market is driven by the increasing prevalence of diabetes, the growing awareness of the importance of early diagnosis and treatment, and the availability of advanced testing technologies. The market is also supported by the increasing demand for point-of-care testing and the development of new products.
Some of the major companies in the HbA1C Testing market include Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, Alere, and Bio-Rad Laboratories. Show Less Read more